Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2

There is currently a lack of biological tools to study the replication cycle and pathogenesis of SARS-CoV-2, the etiological agent of COVID-19. Repurposing the existing tools, including antibodies of SARS-CoV, is an effective way to accelerate the development of therapeutics for COVID-19. Here, we e...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:bioRxiv
Asıl Yazarlar: Bates, Timothy A., Weinstein, Jules B., Farley, Scotland E., Leier, Hans C., Messer, William B., Tafesse, Fikadu G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cold Spring Harbor Laboratory 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7402058/
https://ncbi.nlm.nih.gov/pubmed/32766589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.07.30.229377
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller